AGRANULOCYTOSIS DURING COMBINED PROCAINAMIDE AND PHENYTOIN THERAPY

被引：18

作者：

CROOK, JE

WOOSLEY, RL

LEFTWICH, RB

NATELSON, EA

机构：

[1] Department of Pharmacology, Division of Clinical Pharmacology, Vanderbilt University, Nashville, TN

来源：

关键词：

D O I：

10.1097/00007611-197912000-00032

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1599 / 1601

页数：3

共 6 条

[1] LAWSON DH, 1977, BRIT J CLIN PHARMACO, V4, P507, DOI 10.1111/j.1365-2125.1977.tb00777.x
[2] DRUG-INDUCED AGRANULOCYTOSIS
PISCIOTTA, V
[J]. DRUGS, 1978, 15 (02) : 132 - 143
[3] AGRANULOCYTOSIS ASSOCIATED WITH PROCAINAMIDE THERAPY - REPORT OF A CASE
PRINCE, RA
BROWN, BT
JACKNOWITZ, AI
[J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1977, 34 (12): : 1362 - 1365
[4] REIDENBERG MM, 1975, CLIN PHARMACOL THER, V17, P722
[5] DILANTIN, AGRANULOCYTOSIS, AND PHAGOCYTIC MARROW HISTOCYTES
TSAN, MF
MEHLMAN, DJ
GREEN, RS
BELL, WR
[J]. ANNALS OF INTERNAL MEDICINE, 1976, 84 (06) : 710 - 711
[6] EFFECT OF ACETYLATOR PHENOTYPE ON RATE AT WHICH PROCAINAMIDE INDUCES ANTI-NUCLEAR ANTIBODIES AND LUPUS SYNDROME
WOOSLEY, RL
DRAYER, DE
REIDENBERG, MM
NIES, AS
CARR, K
OATES, JA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (21) : 1157 - 1159